The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

23 May 2022 07:00

RNS Number : 3481M
DeepMatter Group PLC
23 May 2022
 

23 May 2022

 

Alan Aubrey appointed Chairman of DeepMatter

 

DeepMatter Group Plc (AIM: DMTR, "Deepmatter", the "Group"), the digital chemistry data and software company, announces the appointment of Alan Aubrey as non-executive Chairman after the AGM on the 27 May 2022. He takes over from Karen Bach, who is retiring from the board and leaving the Group.

 

Alan has a successful 20-year track record in founding, developing, and growing disruptive technology businesses. He co-founded Techtran Limited in 2002, which was acquired in 2005 by IP Group Plc, a company that develops world-changing science and technology businesses across life sciences, technology and cleantech. Alan was appointed IP Group's CEO shortly after the acquisition and he went on to lead the business to become a member of the FTSE 250.

 

Alan brings significant experience to the Group in the commercialisation of science and the creation of high growth technology businesses that address global markets. Amongst other businesses, Alan has served on the boards of high-profile technology businesses such as Oxford Nanopore Technologies plc and Ceres Power Holdings Plc. He contributed to the growth of dozens of businesses in the life sciences, manufacturing and sustainability industries.

 

Alan is currently non-executive chairman of OxCCU Limited, an Oxford University spin-out focused using CO₂ and renewable energy to make sustainable fuels, chemicals and plastics. He also is a director of both Trellix Limited and Rio AI Limited, which are applying Artificial Intelligence to address business problems.

 

Alan is a Chartered Accountant and from 1995-2001, was a corporate finance partner in KPMG. 

 

Alan is subscribing for 200,000,000 new ordinary shares in the Group at a price of 0.1p per share, prior to his starting date. A further announcement in relation to the subscription will be issued in due course.

Alan currently holds 7,311,393 ordinary shares representing 0.19 per cent of the total voting rights in the Company.

Mark Warne, Chief Executive of DeepMatter, said:

 

"On behalf of everyone at Deepmatter, I would like to thank Karen for her valued contribution and support over the last 20 months which sees the business well positioned for the market opportunity ahead of it. We are delighted that Alan will join us as we enter the next phase of growth."

 

Karen Bach, Chair of Deepmatter said:

 

"Over the past 20 months the Group has built a great team and established the building blocks to commercialise both data and technology. I am proud of the progress we made in this early commercialisation phase. The business has an exciting delivery phase ahead and I wish the team well."

 

Alan Aubrey, Chairman-designate of DeepMatter, commented:

 

"I am joining Deepmatter at a very exciting and dynamic time. Chemistry touches all our lives but the research and development of new chemical formulae remains relatively unsophisticated.

 

"Our vision is to build the capabilities for scientists to access and exploit vast amounts of chemical reaction data. Our SmartChemistry™ platform provides easy access and exploitation of the data in order to make chemical reaction discovery and design faster, safer, more efficient and increasingly sustainable. The recently announced multi-year SmartChemistry™ contracts with Standigm and Springer Nature are evidence of this."

 

For more information contact

 

DeepMatter Group Plc Fraser Benson, Chief Financial Officer 0141 548 8156

Canaccord Genuity Limited (Nominated Advisor and Broker) 020 7523 8000Bobbie Hilliam

Meare Consulting 07990 858548Adrian Duffield

About DeepMatter Group plc 

 

DeepMatter's SmartChemistry™ platform enables scientists across a range of industries, including pharma, biotech, agri-science, scientific publishers and contract research organisations (CROs), to easily capture, access and exploit the vast amounts of data created in chemical reactions.

 

DeepMatter integrates its proprietary chemistry data and proprietary software to significantly improve productivity, efficiency, discovery, safety and sustainability of chemical reactions for its customers.

 

DeepMatter's SmartChemistry™ platform capitalises on the combination of its cloud technology, low cost-sensors, connectivity to laboratory hardware and high-performance computing trends such as artificial intelligence (AI).

 

Visit: www.deepmatter.io and follow @deepmattergroup

 

 

As required under Schedule Two, paragraph (g) of the AIM Rules for Companies, further disclosures on Mr Aubrey are as follows:

 

Mr Alan John Aubrey, aged 61, has held the following directorships and/or partnerships in the past five years:

 

Current directorships and/or partnerships:

IP2IPO Services Limited

Rio Al Limited

Trellix Limited

EUREKA! THE NATIONAL CHILDREN'S MUSEUM

Redcentric plc (effective 22 July 2022)

 

 

 

Past directorships and/or partnerships:

· Top Technology Ventures Limited

· IP Assist Services Limited

· IP2IPO Asia-Pacific Limited

· IP2IPO Innovations Limited

· IP2IPO Limited

· LifeUK (IP2IPO) Limited

· IP Ventures (Scotland) Limited

· IP Industry Partners Limited

· IP2IPO ANZ Carry Limited

· Avacta Group Plc

· IP Group Plc

· MOBILIOn Inc

· Oxford Nanopore Technologies Plc

· IP2IPO Guarantee Limited

· Oxford Science Enterprises Plc

· IP2IPO Management VI Limited

· Proactis Holdings Plc

· IP2IPO Management V Limited

· Ceres Power Intermediate Holdings Limited

· IP2IPO (Europe) Limited

· Ceres Power Holdings Plc

· IP2IPO Management IV Limited

· North East Technology (GP) Limited

· IP Venture Fund (GP) Limited

· Touchstone Innovations Limited

· IP2IPO Management II Limited

· IP2IPO Company Maker Limited

· IP2IPO Management Limited

· IP2IPO US Partners Limited

· Innovations Limited Partner Ltd

· IP2IPO Americas Limited

· Touchstone Innovations Investments Limited

 

There is no further information on Mr Aubrey required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUPWAUPPGBP
Date   Source Headline
24th Jan 20228:50 amRNSHolding(s) in Company
24th Jan 20227:00 amRNSHolding(s) in Company
20th Jan 202212:15 pmRNSResult of General Meeting
20th Jan 20227:00 amRNSResult of Open Offer - Correction
19th Jan 202211:30 amRNSResult of Open Offer
4th Jan 20221:30 pmRNSPosting of Circular and Notice of GM
29th Dec 20214:36 pmRNSPrice Monitoring Extension
24th Dec 20217:00 amRNSPlacing, Subscription and Open Offer
17th Dec 20215:00 pmRNSBusiness Update and Financing
22nd Oct 20217:00 amRNSAppointment of new Scientific Advisory Board
21st Oct 20218:00 amRNSDigitalGlassware® platform trial with Aurigene
28th Sep 20217:00 amRNSCollaboration
22nd Sep 20217:00 amRNSHalf Year Results
14th Sep 202110:30 amRNSNotice of Half Year Results
8th Sep 20211:30 pmRNSHolding(s) in Company
18th Aug 20217:00 amRNSAdvisory Board Appointment
5th Aug 20217:00 amRNSCollaboration with the University of Cambridge
12th Jul 20217:00 amRNSAppointment of Non-Executive Director
30th Jun 20213:34 pmRNSResult of AGM
22nd Jun 20217:00 amRNSChanges to 2021 AGM Arrangements
17th Jun 20217:00 amRNSCollaboration with the University of Leeds
8th Jun 20213:16 pmRNSPosting of ARA and Updated Notice of AGM
1st Jun 20217:00 amRNSFinal Results
24th May 20217:00 amRNSNotice of Results and Investor Presentation
6th May 20213:43 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSCollaboration with the University of Nottingham
11th Mar 20217:00 amRNSCo-distribution agreement with Elemental Machines
9th Mar 20217:00 amRNSDirectorate Change
20th Jan 20217:00 amRNSAgreement with Merck's Life Sciences business
19th Jan 20217:00 amRNSHolding(s) in Company
8th Jan 20212:00 pmRNSPrice Monitoring Extension
18th Dec 202010:30 amRNSGrant of PDMR Options
17th Dec 20207:00 amRNSMulti-year contract with Thieme Chemistry
26th Oct 202011:05 amRNSSecond Price Monitoring Extn
26th Oct 202011:00 amRNSPrice Monitoring Extension
21st Oct 20207:00 amRNSIssue of Shares and Total Voting Rights
19th Oct 20207:00 amRNSDirectorate Changes
16th Oct 20207:00 amRNSStrong adoption of ICSYNTH
2nd Oct 20202:05 pmRNSSecond Price Monitoring Extn
2nd Oct 20202:00 pmRNSPrice Monitoring Extension
1st Oct 20208:00 amRNSGrant of Options
29th Sep 20207:00 amRNSHolding(s) in Company
23rd Sep 20201:40 pmRNSHolding(s) in Company
22nd Sep 20204:29 pmRNSHolding(s) in Company
22nd Sep 20204:00 pmRNSHolding(s) in Company
22nd Sep 202010:32 amRNSHolding(s) in Company
15th Sep 20208:08 amRNSIssue of Shares and Total Voting Rights
10th Sep 20207:00 amRNSHalf-year Report
4th Sep 20208:26 amRNSHolding(s) in Company
3rd Sep 20207:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.